Selection of phage-displayed anti-guinea pig C5 or C5a antibodies and their application in xenotransplantation.
Xenogeneic liver transplantation in the discordant guinea pig (gp) to rat model results in hyperacute rejection within a few minutes, which is due to activation of the complement system. Currently no antibodies against gp complement factors are available, which allow activation of the gp complement system in serum or complement deposition in tissue to be detected. To close this gap, we started developing single chain Fvs (scFvs) against gpC5 and gpC5a. We generated a combinatorial library of scFv antibodies comprising the variable heavy and light chain repertoire from mice immunized with gpC5. Out of this library we selected several antibodies against gpC5 and C5a after four and six rounds of biopanning, respectively. Selected gpC5-specific scFvs were purified by metal affinity chromatography followed by size exclusion chromatography or by affinity chromatography using Protein L. Purified scFvs were able to inhibit gp complement system in a hemolytic assay and to detect gpC5 deposition in tissue. A surface plasmon resonance based assay on BIAcore was established, with which the C5 concentration in gp serum was determined to 240 microg/ml. As at least 0.04% of the normal gpC5 concentration can be detected, the test provides a powerful tool to investigate the development and the consequence of a hybrid complement system after liver xenotransplantation from gp to rat.
Link
C
C
Institute of Medical Microbiology, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Hawlisch
H
H
Meyer zu Vilsendorf
A
A
Gylerüz
S
S
Nagel
E
E
Köhl
J
J
D000208:Acute Disease; D000595:Amino Acid Sequence; D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis / Q000235:genetics / Q000302:isolation & purification*; D000915:Antibody Affinity; D003167:Complement Activation; D003182:Complement C5 / Q000235:genetics / Q000276:immunology*; D015936:Complement C5a / Q000235:genetics / Q000276:immunology*; D003169:Complement Inactivator Proteins / Q000096:biosynthesis / Q000235:genetics / Q000302:isolation & purification; D003429:Cross Reactions; D006084:Graft Rejection / Q000209:etiology / Q000276:immunology; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology; D007114:Immunization; D016031:Liver Transplantation / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D019151:Peptide Library; D051381:Rats; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous
D000910:Antibodies, Heterophile; D003182:Complement C5; D003169:Complement Inactivator Proteins; D019151:Peptide Library; D015936:Complement C5a